Quantum Genomics Employees 2024

Quantum Genomics Aktienanalyse

What does Quantum Genomics do?

Quantum Genomics SA is a French biotechnology company focused on the discovery and development of novel therapies for the treatment of cardiovascular diseases. The company was founded in 2005 in Grenoble, France, where its headquarters are still located. Over 25 employees are currently working on the development of new drugs. The business model of Quantum Genomics SA is based on the research and development of new and innovative solutions for the cardiovascular disease market. The company focuses on a new class of drugs that target the brain to lower blood pressure and treat certain cardiovascular diseases. The goal of these new therapies is to improve the effectiveness of existing treatment methods by directly addressing the causes of the disease. Quantum Genomics SA has established partnerships with renowned research institutes and universities. The collaboration with these institutions aims to accelerate and intensify the research and development of new drugs. Through this collaboration, the company will be able to develop new solutions and therapies to treat cardiovascular diseases at a faster pace. The company is currently working on two main products: Firibastat and the QT-Glutamylcyclotransferase inhibitor. Firibastat is an oral medication developed for the treatment of hypertension. The QT-Glutamylcyclotransferase inhibitor is another medication that is intended to lower blood pressure. These are promising new solutions that can enable Quantum Genomics SA to play a significant role in the cardiovascular disease market. The products of Quantum Genomics SA aim to treat cardiovascular diseases better and more effectively by directly targeting the brain. This aims to reduce the risk of serious complications and side effects that may occur with conventional medications. In recent years, Quantum Genomics SA has received several awards, including the "Innovation Prize" from the French government. These awards demonstrate that the company is on the right track and achieving its goals. Overall, Quantum Genomics SA has a promising business model based on the development of new therapies for the treatment of cardiovascular diseases. With collaborations with renowned research institutes and the development of promising new products, the company is well-positioned to be successful and make significant progress in the growing market of cardiovascular diseases. Quantum Genomics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Quantum Genomics's Employee Base

Quantum Genomics's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Quantum Genomics's operational capacity and future potential.

Year-to-Year Comparison

Assessing Quantum Genomics's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Quantum Genomics's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Quantum Genomics’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Quantum Genomics Stock

How many employees does Quantum Genomics have this year?

Quantum Genomics has 12 undefined employees this year.

How many employees did Quantum Genomics have compared to the previous year?

Compared to the previous year, Quantum Genomics had 0% more employees.

What impact did the number of employees have on the company Quantum Genomics?

The number of employees has a direct impact on the efficiency and productivity of Quantum Genomics. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Quantum Genomics?

The number of employees can also have an impact on investors of Quantum Genomics, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Quantum Genomics affect the company?

An increase in equity of Quantum Genomics can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Quantum Genomics's equity affect the company?

A reduction in equity of Quantum Genomics can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Quantum Genomics?

Some factors that can influence the equity of Quantum Genomics include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Quantum Genomics so important for investors?

The equity of Quantum Genomics is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Quantum Genomics influence the company?

The number of employees at Quantum Genomics can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Quantum Genomics evolved in recent years?

In recent years, the number of employees at Quantum Genomics has changed by 0.

How many employees does Quantum Genomics currently have?

Quantum Genomics currently has 12 undefined employees.

Why is the number of employees important for investors of Quantum Genomics?

The number of employees is important for investors of Quantum Genomics as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Quantum Genomics take to change the number of employees?

To change the number of employees, Quantum Genomics can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Quantum Genomics pay?

Over the past 12 months, Quantum Genomics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Quantum Genomics is expected to pay a dividend of 0 EUR.

What is the dividend yield of Quantum Genomics?

The current dividend yield of Quantum Genomics is .

When does Quantum Genomics pay dividends?

Quantum Genomics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Quantum Genomics?

Quantum Genomics paid dividends every year for the past 0 years.

What is the dividend of Quantum Genomics?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Quantum Genomics located?

Quantum Genomics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Quantum Genomics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Quantum Genomics from 7/2/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 7/2/2024.

When did Quantum Genomics pay the last dividend?

The last dividend was paid out on 7/2/2024.

What was the dividend of Quantum Genomics in the year 2023?

In the year 2023, Quantum Genomics distributed 0 EUR as dividends.

In which currency does Quantum Genomics pay out the dividend?

The dividends of Quantum Genomics are distributed in EUR.